Key result
Deactivation of automatic implantable cardioverter-defibrillators in patients with terminal diagnoses is presented as a moral right to prevent the pain and distress of nontherapeutic discharge.
Population
Patients at the end of life with terminal and life-limiting diagnoses in hospice and home care settings who…
Design
Review
Authors
Loading...
Supports ethical AICD deactivation discussions in terminal hospice care; leaves open prospective studies on implementation and outcomes.
Presents a moral argument and policy recommendations for deactivating AICDs in end-of-life hospice and home care patients to prevent distress from nontherapeutic shocks.
Timothy W. Kirk (2008) studied Terminal and life-limiting diagnoses with active AICDs. Deactivation of Automatic Implantable Cardioverter-Defibrillators (AICDs) was evaluated. Deactivation of automatic implantable cardioverter-defibrillators in patients with terminal diagnoses is presented as a moral right to prevent the pain and distress of nontherapeutic discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: